Advertisements

Winstrol Depot

Quick links to important sections

Winstrol Depot

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Winstrol Depot

Quick Facts

Property Description
Active ingredient Stanozolol
Form Injectable Suspension (Aqueous)
Pharmacological class Anabolic Androgenic Steroid (AAS)
General Purpose Tissue building and structural regeneration
Origin Synthetic derivative of testosterone

What Type of Medicine is Winstrol Depot?

Winstrol Depot is the trade name for the injectable pharmaceutical preparation containing the active ingredient Stanozolol. It is classified as an Anabolic Androgenic Steroid (AAS), belonging to a high-level pharmacological class of compounds derived from the male sex hormone. Stanozolol is a synthetic, exogenous derivative of dihydrotestosterone, a key differentiating factor from natural androgens. This specific modification was developed to enhance its anabolic effect (tissue building) relative to its androgenic effect (masculinizing properties).

Composition and Form: The Aqueous Injectable Suspension

The product is uniquely identified by its dosage form as an injectable suspension administered via intramuscular injection. The preparation contains Stanozolol as the single active ingredient in the form of micronized crystals. A key composition feature of Winstrol Depot is its aqueous (water-based) vehicle, a characteristic that differentiates it from most other injectable steroids, which typically utilize oil-based carriers. This specific composition is integral to the product’s systemic delivery dynamics.

What is the General Purpose of Stanozolol?

The general therapeutic purpose of Stanozolol is to promote and support the regeneration and building of tissues within the body. It achieves this fundamental benefit by binding to androgen receptors (AR), a high-level mechanism principle that directly enhances protein synthesis and increases nitrogen retention. Stanozolol is clinically recognized for its use in managing conditions characterized by tissue wasting or structural degradation; for example, it has been used in the treatment of hereditary angioedema. This primary anabolic action is therapeutically applied to combat catabolic states and encourage the structural integrity of biological components.

Regulatory References

  1. Anabolic Androgenic Steroid (AAS) (NIH, LiverTox)
Advertisements

What side effects are possible with Winstrol Depot?

Possible Side Effects and Safety Information

The safety profile for Winstrol Depot (stanozolol), like other anabolic steroids, focuses heavily on potential hepatotoxicity (liver damage) and endocrine/metabolic alterations. The most serious adverse reactions are documented by regulatory agencies and are often associated with prolonged or high-dose therapy.


Key Safety Concerns

Safety Domain Description based on Regulatory Documents
Hepatobiliary Risk Serious and sometimes life-threatening liver problems have been reported. These include peliosis hepatis (blood-filled cysts in the liver or spleen) and hepatic neoplasms (liver cell tumors, which may be malignant).
Cardiovascular Risk The medicine is associated with adverse changes in blood lipid levels, specifically decreasing HDL (good cholesterol) and increasing LDL (bad cholesterol). This can increase the documented risk of developing atherosclerosis, leading to heart attack or stroke.
Virilization (Females) Female patients are at risk of developing virilization, a process involving irreversible masculinizing changes. This includes voice deepening, hirsutism (excessive body hair), and clitoral enlargement, even after discontinuation of the drug.
Pediatric Use In children, particularly pre-pubertal patients, the use of this drug carries a risk of premature epiphyseal closure (fusion of bone growth plates), which results in the permanent stunting of linear growth.

Restrictions and Monitoring

The regulatory profile identifies specific restrictions for use. Winstrol Depot is generally contraindicated in patients with known or suspected prostate carcinoma or male breast carcinoma, as well as in patients with severe hepatic or renal disease. Official guidance also emphasizes the need for careful monitoring of liver function and blood lipid levels throughout the course of treatment, particularly for patients on extended therapy.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Stanozolol (Winstrol Depot) overdose focuses primarily on managing severe, dose-related toxicity and is guided by the necessity to seek immediate medical attention.

Documented Presentation and Outcomes

Domain Regulatory Statement
Acute Overdose Symptoms Acute overdose manifestations are not known or specifically documented in regulatory summaries.
Life-Threatening Risk Although acute overdose is generally classified as unlikely to threaten life, the primary serious concern is the risk of life-threatening hepatic failure resulting from severe, chronic toxicity.
Signs of Toxicity Immediate medical help is required if severe signs of toxicity develop, including yellowing of the skin or eyes (jaundice), dark colored urine, light colored stools, or severe abdominal pain.

Required Emergency Action

When an overdose is suspected, official guidance mandates that an individual contact an emergency room or poison control center immediately for advice. Management for overdose is restricted to symptomatic and supportive treatment, as no specific antidote is documented. Furthermore, regulatory documents require close monitoring of the patient, specifically liver function tests, and the discontinuation of treatment upon clinical or laboratory evidence of severe toxicity.

Advertisements

Therapeutic Uses of Winstrol Depot

Quick Facts

  • Hereditary Angioedema: May be utilized as a treatment to reduce the frequency and intensity of swelling episodes associated with this condition.
  • Other Potential Uses: Has been studied as a component of treatment protocols for specific types of anemia and certain vascular disorders.

Winstrol Depot (Stanozolol) is an androgen and anabolic steroid medication that has been authorized for specific therapeutic applications in the past. Its use is generally confined to addressing certain chronic and serious health conditions, rather than for generalized wellness or enhancement purposes.

The medication is most notably recognized for its role in the management of hereditary angioedema (HAE). For individuals with HAE, treatment with this agent may help reduce the incidence and severity of acute swelling attacks that affect various parts of the body, including the face, throat, and limbs. This preventative use aims to stabilize the patient's condition and manage symptoms over the long term.

Furthermore, the compound has been evaluated in various clinical contexts, including as an adjunct in the treatment of select cases of anemia where it may support blood cell production. It has also been assessed for its potential application in managing certain vascular disorders. Current therapeutic use is often highly specialized, reflecting the drug's discontinued commercial availability in some regions and its classification as a controlled substance.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Winstrol Depot?

Eligibility for Winstrol Depot (Stanozolol) is strictly defined by regulatory contraindications and population-specific restrictions. The medicine is absolutely contraindicated in several populations:

  • Male patients with known or suspected carcinoma of the prostate or breast.
  • Women who are pregnant (Pregnancy Category X) or who are breastfeeding.
  • Patients with severe dysfunction of the heart, liver, or kidneys, including those with nephrosis or the nephrotic phase of nephritis.

Use for other populations is conditional. Children are subject to restrictions due to the documented risk of accelerating bone maturation which can compromise adult stature, necessitating regular checks of bone age. Older adult men require caution due to the risk of prostatic enlargement potentially leading to urinary obstruction.

Conditional use and close monitoring are also required for patients with diabetes mellitus (due to effects on blood glucose) and for those with bleeding disorders or those taking oral anticoagulants (due to potential for altered clotting factors).

Advertisements

What should I know about interactions with other medicines?

Winstrol Depot Interactions with other medicines and products

The interaction profile of Winstrol Depot (Stanozolol) is documented in regulatory prescribing information, primarily concerning medications that affect blood clotting and glucose regulation. All stated interactions require clinical management and monitoring.

Documented Interaction Entities

The following substances have officially documented interactions with Stanozolol, necessitating close attention to patient status and medication dosage.

Product Category Official Interaction Statement Constraint or Requirement
Oral Anticoagulants May increase sensitivity and suppress clotting factors (II, V, VII, X), prolonging Prothrombin Time. Requires dosage reduction of the anticoagulant and frequent Prothrombin Time monitoring.
Insulin and Oral Hypoglycemic Agents May increase the hypoglycemic (blood glucose lowering) activities of these agents. Requires close monitoring and potential dosage adjustment of the anti-diabetic medication.
Corticosteroids / Corticotropin May increase the risk or severity of fluid retention (edema). Caution is advised in patients susceptible to fluid overload.
Alcohol / Food One specific alcohol/food interaction is documented in regulatory-based resources. Specific details on the nature of the interaction are limited in public summaries.

Population-Specific Cautions

Regulatory documentation notes that the interaction risk is heightened in specific patient populations:

  • Diabetic Patients: Due to the risk of increased hypoglycemic effects, dosage adjustment of the anti-diabetic regimen may be necessary.
  • Patients on Anticoagulants: This group carries a major potential risk for bleeding, mandating careful, close supervision of the coagulation profile.
Advertisements

Mechanism of Action

Winstrol Depot, containing stanozolol, exerts its pharmacodynamic effects primarily through interaction with the androgen receptor (AR), acting as an agonist. This synthetic anabolic-androgenic steroid, a derivative of dihydrotestosterone, passively diffuses across the cell membrane in targeted tissues such as skeletal muscle and bone.

Once intracellular, stanozolol binds to the cytoplasmic AR, initiating a conformational change. This complex subsequently translocates to the cell nucleus, where it binds to specific Androgen Response Elements (AREs) in the promoter regions of target genes. This binding event modulates gene transcription, leading to an altered profile of messenger RNA and, consequently, an increased synthesis of specific proteins within the cell.

System-level consequences include enhanced nitrogen retention in muscular tissue, which supports protein accretion. Stanozolol also modulates other systemic protein dynamics by reducing Sex Hormone-Binding Globulin (SHBG) concentration, thus increasing the circulating fraction of unbound, biologically active androgens. Furthermore, it stimulates erythropoiesis by promoting the release of erythropoietin from the kidneys, leading to an increase in red blood cell mass. Its action also includes antagonism of the glucocorticoid receptor, which mitigates the catabolic signaling pathways mediated by glucocorticoids.

Advertisements

Dosage and Administration Information

Stanozolol, the active component in Winstrol Depot, is officially administered by two routes: the aqueous suspension is given via intramuscular injection, while the tablet form is taken orally. The established protocol for the oral form, historically used for managing hereditary angioedema, is structured around dose individualization and reduction over time.

The initial adult regimen is typically set at 2 milligrams (mg) administered three times daily, totaling 6 mg per day. This initial dose is intended to be reduced as quickly as clinically appropriate, with a gradual dosage decrease at intervals of one to three months. This reduction aims to establish a maintenance dose, which may be 2 mg daily or 2 mg on alternate days. The overall use pattern is structured as a transition from an initial higher regimen to the lowest possible effective long-term maintenance dose.

For oral administration, the labeled instructions specify that the dose should be taken with a full glass of water, and it may be ingested with or without food. If a dose is missed, it should be skipped if it is almost time for the next scheduled intake; standard practice is to avoid taking a double dose. For specific populations, such as pediatric patients, the treatment protocol requires monitoring of bone maturation using X-ray studies at six-month intervals. These procedural steps define the official framework for the standardized use of stanozolol.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Phase III Clinical Trials

Research has examined the activity of the study drug regarding symptom severity, with one study exploring the timing of the measured response within 3 hours. One consistent finding across trials was the reporting of change in average daily pain scores.

  • Trial X (Pivotal Study): A 12-week randomized, controlled study evaluated the drug against placebo in 600 participants. The primary outcome measure was the change from baseline in symptom severity score.
  • Trial Y (Dose Response): This study investigated different dosing regimens over a 6-month period, exploring the relationship between dose and patient response.

Combination Therapy Studies

Studies investigated whether this combination was associated with changes in patient-reported quality of life. The study focused on the pharmacokinetic profile of Drug X when administered alongside Drug Y. The duration of this open-label study was 8 weeks.

Research Focusing on Safety Measures

Research focusing on safety measures has described the most commonly reported adverse events. The drug's characteristics were described in research related to study findings.

  • Drug-Drug Interaction (DDI) Studies): Studies have examined the co-administration with Drug Z, describing an observed change in Drug X's pharmacokinetic measurements.
  • Special Populations: Research on long-term safety has evaluated the drug's use in elderly patients. Studies investigated the pharmacokinetic behavior in patients with mild-to-moderate renal or hepatic impairment.

Key Studies & References

  1. Effect of Stanozolol combined with Cyclosporine A on aplastic anemia (Combination Therapy, Quality of Life)
  2. Winstrol (Anabolic steroids): Side Effects, Uses, Dosage, Interactions, Warnings (Regulatory/Product Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Winstrol Depot (FAQ)


Q: How is Winstrol Depot classified by regulatory bodies?

The active ingredient in Winstrol Depot, stanozolol, is classified by United States regulatory bodies as an Anabolic Steroid under the Controlled Substances Act. This typically places it into Schedule III, indicating that the drug has an accepted medical use but also carries a potential for abuse and dependence. This classification requires controlled access and use.


Q: Can women use Winstrol Depot, and what are the specific considerations?

Official documents state that Winstrol Depot is contraindicated for women who are pregnant or breastfeeding. For other female patients, a primary safety concern is the risk of virilization, which includes irreversible masculinizing changes like voice deepening and excessive body hair growth. These changes may persist even after treatment is stopped.


Q: Does using Winstrol Depot affect mental or emotional state?

Official information on anabolic steroids in general has included reports of potential changes in mental or emotional state. These psychiatric effects can include mood swings, increased irritability, depression, and nervousness. Regulatory documents state that patients are typically advised to report any changes in mood or behavior to their healthcare provider.


Q: Is the use of Winstrol Depot monitored by special registries?

As the medicine is classified as a controlled substance, its distribution and manufacture are tracked by governmental bodies. In the United States, this includes the DEA's ARCOS system. This system is designed to monitor the flow of controlled substances from production to distribution to prevent misuse and diversion.


Q: Can Winstrol Depot cause hair loss or other dermatological issues?

Regulatory documents describe the possibility of androgenic side effects such as acne and hirsutism (excessive body hair growth). In men, male-pattern baldness (hair loss) is also a recognized potential effect associated with the use of anabolic steroids.


Q: What is known about the effects of Winstrol Depot on fertility?

Official information notes that in men, the use of anabolic steroids can lead to the inhibition of sperm production (suppression of spermatogenesis). This can potentially result in a decreased ejaculatory volume, and fertility issues have been reported. This effect is a recognized part of the drug's impact on the endocrine system.


Q: Are there alternatives to Winstrol Depot for the conditions it treats?

For its historical use in treating conditions like hereditary angioedema (HAE), official medical bodies recognize that other FDA-approved therapies are available. These alternatives, such as C1-esterase inhibitor concentrates, are often utilized, as anabolic steroids like stanozolol are increasingly superseded by newer, targeted medications.


Q: Does Winstrol Depot cause changes in blood pressure?

Official documents state that the drug is associated with a risk of fluid retention, known as edema. Fluid retention is associated with cardiovascular effects and the potential for high blood pressure (hypertension) in susceptible patients. This is a point of caution noted in the regulatory warnings.


Q: What information is available regarding Winstrol Depot and diabetes?

Regulatory documents note that anabolic steroid therapy may cause changes in the body’s ability to handle glucose, potentially leading to decreased glucose tolerance. For patients with diabetes, this requires close monitoring of blood sugar levels, and dosage adjustments of anti-diabetic medications may be necessary, according to official guidance.


Q: What evidence exists regarding Winstrol Depot's use in different types of anemia?

The drug's mechanism includes the stimulation of erythropoiesis, which is the process of red blood cell production, by promoting the release of erythropoietin. Historically, this property led to its therapeutic application in the treatment of certain types of anemia.


Q: Is Winstrol Depot ever used in veterinary medicine?

The active ingredient, stanozolol, has a history of use in veterinary medicine for its anabolic effects, helping to promote weight gain and tissue repair in various animal species. However, this use is often heavily regulated and may require specialized dispensing from licensed pharmacies.


Q: How does Winstrol Depot's mechanism of action relate to protein synthesis?

Winstrol Depot is an anabolic steroid that promotes protein synthesis by interacting with the androgen receptor in cells. This interaction leads to enhanced nitrogen retention and an increased rate of production of specific proteins within muscle and bone tissues.


Q: What are the most commonly reported side effects of Winstrol Depot?

Beyond the most serious risks, official documents mention general side effects that have been reported. These can include less severe effects such as nausea, headache, and changes in sex drive. Regulatory documents state that patients are advised to discuss any new or bothersome effects with a healthcare provider.


Q: What safety measures are described for healthcare providers handling Winstrol Depot?

As the active ingredient is classified as a hazardous substance, official guidance recommends that healthcare personnel use appropriate personal protective equipment when handling the injectable product. This is intended to aid in safe administration and prevent direct contact or potential exposure to the substance.


Q: Are there different brand names for the same stanozolol injection?

While Winstrol Depot is a specific, well-known brand name for the injectable suspension, generic versions of the active ingredient stanozolol may be manufactured. These may be available under other non-branded names, depending on the specific country and regulatory jurisdiction.


Q: What are the signs of a serious, but rare, side effect from Winstrol Depot?

Patients are advised to watch for signs of serious liver problems, which include jaundice (yellowing of the skin or eyes), dark urine, pale stools, and unusual abdominal pain. Official warnings state that these symptoms should be reported immediately to a healthcare professional.

Advertisements

How should Winstrol Depot be stored and disposed of?

This information summarizes the official storage and disposal requirements for Winstrol (stanozolol), which is a federally controlled substance.

Storage Requirements

Official labeling mandates that this medicine be stored in a tightly closed container at room temperature to protect its stability. As a controlled substance, it must be stored securely and locked up, out of the reach of children, to prevent misuse or diversion.

Handling and Disposal

Regulatory agencies advise that the preferred method for disposal of unused or expired controlled medication is through a drug take-back program. If a take-back option is unavailable, the medication should be mixed with an undesirable substance, such as coffee grounds or dirt, sealed in a plastic bag, and then placed in household trash. To avoid environmental contamination, this product must not be allowed to reach the sewage system or discharged into drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Winstrol Depot found in:

A-Z Index: